ArticleCardiovascular drugs and therapy2022

Response to the Letter on "The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus".

Bertram Pitt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.